相关实验视频
Updated: Jul 11, 2025

08:08
Simulator Training for Endovascular Neurosurgery
Published on: May 6, 2020
3.7K
对于患有冠状动脉狭窄症的患者的决策辅助工具
Brianna M Krafcik1, Isabel A Jarmel2, Jocelyn M Beach3
1Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Journal of vascular surgery
|November 3, 2023
概括
临床医生对动脉狭窄症的共享决策工具的使用不足. 目前的工具不包括所有治疗选择,需要开发更好的患者护理辅助工具.
科学领域:
- 医疗决策的制定 医疗决策的制定
- 医疗保健服务研究 医疗服务研究
- 血管外科 血管外科
背景情况:
- 共享决策 (SDM) 工具在临床实践中未得到充分利用.
- 医疗保险覆盖范围的变化对于状动脉支架授权SDM,需要验证的工具.
- 这项研究解决了评估动脉狭窄现有决策辅助器的需要.
研究的目的:
- 评估目前可用的决定辅助工具,用于治疗动脉狭窄症.
- 评估决策辅助格式和患者特征对治疗选择的影响.
- 识别有关动脉再血管化的现有决策支持工具的差距.
主要方法:
- 对治疗动脉疾病的决策辅助器的系统性文献综述.
- 包括报告决策辅助格式,患者理解和决策结果的研究.
- 对决策辅助工具的分析,以包括相关的治疗选择.
主要成果:
- 四个出版物符合审查的纳入标准.
- 决策辅助格式对患者的理解和决策产生了重大影响.
- 患者的特征也在治疗决策中发挥了作用.
- 没有可用的决策辅助工具包括跨动脉复血管化 (TCAR) 作为一种选择.
结论:
- 需要进一步的研究来开发一种有效的决定辅助工具来治疗动脉狭窄症.
- 现有的决策辅助工具需要改进,以纳入所有相关的治疗选择,包括TCAR.
- 增强的决策支持工具对于有效的共同决策在动脉疾病管理中至关重要.
相关概念视频
Atherosclerosis IV: Nursing Management
17
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
17
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
10
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
10
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Angina IV: Management
9
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9

